Frontiers in Public Health | www.frontiersin.org 1 June 2017 | Volume 5 | Article 127
Overcoming HIV-related stigma and discrimination in health- care settings and beyond
UNAIDS 2017 | REFERENCE
"This is the final report of the six-year collaboration between the WHO Department of Mental Health and Substance Abuse and the Gulbenkian Global Mental Health Platform, an initiative of the Calouste Gulbenkian Foundation aimed at reducing the global burden of mental health through the development a...nd application of evidence and good practices to global mental health."
more
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 11, November 2017
Teaching the Sustainable Development Goals” provides information about the SDGs, their background, the global reality and offers assistance and suggestions on how to teach and support learning for sustainable development.
This I-Kit provides essential information and tools for responding to an outbreak using an SBCC approach. It presents a series of nine units, each accompanied by exercise worksheets to help link the SBCC theory to practice.
The worksheets in each section are typically followed by a completed exam...ple. The completed examples will likely include information about an emergency that, during an actual event, might not be immediately available. This was done to illustrate the full range of information to inform a strategic communication response.
more
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more